SK Biopharmaceuticals Co., Ltd. (326030) Revenue

― Followers

SK Biopharmaceuticals Co., Ltd. Revenue

SK Biopharmaceuticals Co., Ltd. had a revenue of 247.37B in the quarter ending Jun 30, 2026, with 8.55%. This bring the company's revenue in the last twelve months to 861.34B, Decreased 9.00%. In the fiscal year ending Dec 31, 2025, SK Biopharmaceuticals Co., Ltd. had annual revenue of 706.74B with 29.06% growth.

Revenue (ttm)

861.34B

Revenue Growth

38.86%

P/S Ratio

8.30

Revenue/Employee

₩2,932,535,104

Employees

241

Market Cap

₩5.87T

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	706.74B	159.14B	+29.06%
Dec 31, 2024	547.60B	192.70B	+54.30%
Dec 31, 2023	354.89B	108.71B	+44.16%
Dec 31, 2022	246.18B	-172.47B	-41.20%
Dec 31, 2021	418.64B	392.65B	+1,510.23%
Dec 31, 2020	26.00B	-97.85B	-79.01%
Dec 31, 2019	123.85B	122.75B	+11,172.24%
Dec 31, 2018	1.10B	-84.22B	-98.71%
Dec 31, 2017	85.32B	―	―